1. Home
  2. GRDN vs DXPE Comparison

GRDN vs DXPE Comparison

Compare GRDN & DXPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRDN
  • DXPE
  • Stock Information
  • Founded
  • GRDN 2004
  • DXPE 1908
  • Country
  • GRDN United States
  • DXPE United States
  • Employees
  • GRDN N/A
  • DXPE N/A
  • Industry
  • GRDN Retail-Drug Stores and Proprietary Stores
  • DXPE Industrial Machinery/Components
  • Sector
  • GRDN Consumer Staples
  • DXPE Industrials
  • Exchange
  • GRDN Nasdaq
  • DXPE Nasdaq
  • Market Cap
  • GRDN 1.8B
  • DXPE 1.9B
  • IPO Year
  • GRDN 2024
  • DXPE 1996
  • Fundamental
  • Price
  • GRDN $27.24
  • DXPE $115.82
  • Analyst Decision
  • GRDN Strong Buy
  • DXPE Buy
  • Analyst Count
  • GRDN 2
  • DXPE 1
  • Target Price
  • GRDN $24.50
  • DXPE $95.00
  • AVG Volume (30 Days)
  • GRDN 345.7K
  • DXPE 143.0K
  • Earning Date
  • GRDN 11-11-2025
  • DXPE 11-03-2025
  • Dividend Yield
  • GRDN N/A
  • DXPE N/A
  • EPS Growth
  • GRDN N/A
  • DXPE 47.94
  • EPS
  • GRDN N/A
  • DXPE 5.24
  • Revenue
  • GRDN $1,326,604,000.00
  • DXPE $1,919,100,000.00
  • Revenue This Year
  • GRDN $16.17
  • DXPE $11.37
  • Revenue Next Year
  • GRDN $2.31
  • DXPE $4.63
  • P/E Ratio
  • GRDN N/A
  • DXPE $22.18
  • Revenue Growth
  • GRDN 18.53
  • DXPE 13.93
  • 52 Week Low
  • GRDN $14.16
  • DXPE $48.45
  • 52 Week High
  • GRDN $30.39
  • DXPE $129.56
  • Technical
  • Relative Strength Index (RSI)
  • GRDN 54.36
  • DXPE 47.42
  • Support Level
  • GRDN $27.35
  • DXPE $110.51
  • Resistance Level
  • GRDN $30.39
  • DXPE $121.29
  • Average True Range (ATR)
  • GRDN 1.16
  • DXPE 5.03
  • MACD
  • GRDN -0.09
  • DXPE -1.52
  • Stochastic Oscillator
  • GRDN 40.47
  • DXPE 27.87

About GRDN Guardian Pharmacy Services Inc. Class A Common Stock

Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.

About DXPE DXP Enterprises Inc.

DXP Enterprises Inc is a distributor of products and services to industrial customers in the United States, Canada, Mexico, and Dubai. The company's reportable segments include Service Centers, Innovative Pumping Solutions, and Supply Chain Services. It generates maximum revenue from the Service Centers segment. The company offers pumping solutions, supply chain services and maintenance, repair, operating, and production services for rotating equipment, bearings, power transmissions, industrial supplies, and safety products. It serves the General Industrial, Oil & Gas, Food & Beverage, Water & Wastewater, Chemical, Transportation, Aerospace & Others.

Share on Social Networks: